GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » NonCurrent Deferred Liabilities

Albert Labs International (XCNQ:ABRT) NonCurrent Deferred Liabilities : C$0.00 Mil (As of Sep. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Albert Labs International NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Albert Labs International's non-current deferred liabilities for the quarter that ended in Sep. 2023 was C$0.00 Mil.

Albert Labs International NonCurrent Deferred Liabilities Historical Data

The historical data trend for Albert Labs International's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert Labs International NonCurrent Deferred Liabilities Chart

Albert Labs International Annual Data
Trend Dec21 Dec22
NonCurrent Deferred Liabilities
- -

Albert Labs International Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Albert Labs International NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of Albert Labs International's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Albert Labs International Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » NonCurrent Deferred Liabilities
Comparable Companies
XCNQ:MYND XCNQ:ENBI TSXV:IBO XCNQ:HAVN XCNQ:GTTX XCNQ:MOOD XCNQ:WESA.X TSXV:BTI XCNQ:AGN XCNQ:CURE OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
6996, Merritt Avenue, Burnaby, BC, CAN, V5J 4R6
Website
https://www.albertlabs.com
Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.

Albert Labs International Headlines

No Headlines